Europe Automated Compounding Systems Market 2027 Product Type, End User, and Country

Europe Automated Compounding Systems Market Forecast to 2027 - COVID-19 Impact and Regional Analysis By Product Type (Gravimetric Automated Compounding Systems, Volumetric Automated Compounding Systems); End User (Hospitals, Chemotherapy Centers, Others), and Country

Publication Month : Jul 2020

  • Report Code : TIPRE00012189
  • Category : Medical Device
  • Status : Published
  • No. of Pages : 93
Inquire Before Buy

PRICING

$3000

$1800

The Europe automated compounding systems market is expected to reach US$ 182.88 million by 2027 from US$ 111.28 million in 2019. The market is estimated to grow with a CAGR of 6.6% from 2020 to 2027.

The growth of the market is driven by factors such as the growing adoption of chemotherapy and personalized medication and rising need to minimize medication errorsin the Europe region. However, high cost and reluctance to adopt the automated compounding systems and COVID-19 pandemicis likely to restrain the market growth to a certain extent.

Automated compounding system is a device that combines one or more drug solutions to final container for patient administration. Automated compounding system helps avoid medication error that occurs due to variety of factors such as poor management communication between the physician and pharmacist, critical storage practices in pharmacies, and confusion that was arising out of the use of similar labels. However, with the automated compounding systems, the accuracy as well as efficiency of dispensing compounded products have improved, and it has further reduced the exposure of healthcare professionals to toxic agents.

Several manufacturers are developing robotics automating compounding systems. For instance, the robotic arms of Kiro Oncology® (Grifols) perform separate tasks simultaneously, the movement of disposable items are minimized in the compounding area and the decontamination of hazardous chemicals is realized by self-cleaning. Kiro Oncology® is classified as a class II A2 biosafety cabinet and the compounding are is ISO 5 classified. For instance, the intelligent compounding system (= ICS®, Steriline) is a fully automated robotic solution, based on isolator technology, controlled by software, which compounds parenteral medication doses into the appropriate final containers within a controlled environment (ISO class 4.8, grade A). It includes a bio-decontamination system with vaporized H2O2 sterilization technology; therefore, it can be installed in an ISO class 8 (grade D) background environment. The ICS® can handle both hazardous and non-hazardous medications and both patient specific and batch production. The ICS includes state of the art automation and robotics to perform the following tasks without requiring human intervention. Therefore, innovative technology of robotics automation in compounding systems is a major factor for the market growth.

The rapid adoption of novel therapies, such as chemotherapy in oncology has been reported to provide better treatment options for breast, lung, and prostate cancers. Similarly, the area of precision and personalized medicine (PPM) is developed to make therapies for a single patient or specific groups based on data that captures current and past physical health and environmental experience. Recently, several reports show that the assimilation of PPM viewpoint into cancer research and treatment will result into significant enhancements in fighting cancer, mainly due to its complexity and interpatient unpredictability.

Several manufactures offer automated compounding systems toward chemotherapy and personalized medicines. For instance, Pharmoduct (Comecer) is an automated device used for the sterilized preparation of personalized oncology drugs, which includes chemotherapy and biologicals. Therefore, the increasing adoption of chemotherapy is ranked among the leading factors for the growth of the Europe automated compounding systems market

Europe has been massively hit by COVID-19 outbreak affecting many of its countries on a large scale. Italy, Germany, Spain, UK and France along with other European countries are continually witnessing rise in number of COVID-19 cases every day. In March 2020, European Medicines Agency has formed an executive committee to deal with impact of COVID-19 on supply chain of medicines. Moreover, the process of shutting down is expected to have severe impact on new product launches and distributions. For instance, Comecer is headquartered in Italy with its factories in Italy and the Netherlands due to the lockdown and severe spread of COVID-19 and complete lockdown in the country will affect the manufacturing process of automated compounding systems.

Rest of Europe Automated Compounding Systems Market Revenue and Forecasts to 2027 (US$Mn)

Rest of Europe Automated Compounding Systems Market Revenue and Forecasts to 2027 (US$Mn)
  • Sample PDF showcases the content structure and the nature of the information with qualitative and quantitative analysis.
  • Request discounts available for Start-Ups & Universities

EUROPEAUTOMATED COMPOUNDING SYSTEMS MARKET SEGMENTATION

ByProduct Type

  • Gravimetric Automated Compounding Systems
  • Volumetric Automated Compounding Systems


ByEnd Users

  • Hospitals
  • Chemotherapy Centers
  • Others


By Country

  • Germany
  • France
  • UK
  • Italy
  • Spain

Companies Mentioned

  • Braun Melsungen AG
  • Comecer
  • Grifols, S.A
  • NewIcon
  • Baxter International Inc.
Report Coverage
Report Coverage

Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends

Segment Covered
Segment Covered

Product Type, End User, and Country

Regional Scope
Regional Scope

North America, Europe, Asia Pacific, Middle East & Africa, South & Central America

Country Scope
Country Scope

UK, Germany, France, Italy, Russia

The List of Companies - Europe Automated Compounding Systems Market

  1. Braun Melsungen AG
  2. Comecer
  3. Grifols, S.A
  4. NewIcon
  5. Baxter International Inc.

The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.

  1. Data Collection and Secondary Research:

As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.

Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.

  1. Primary Research:

The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.

For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.

A typical research interview fulfils the following functions:

  • Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
  • Validates and strengthens in-house secondary research findings
  • Develops the analysis team’s expertise and market understanding

Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:

  • Industry participants: VPs, business development managers, market intelligence managers and national sales managers
  • Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.

Below is the breakup of our primary respondents by company, designation, and region:

Research Methodology

Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.

  1. Data Analysis:

Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.

  • 3.1 Macro-Economic Factor Analysis:

We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.

  • 3.2 Country Level Data:

Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.

  • 3.3 Company Profile:

The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.

  • 3.4 Developing Base Number:

Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.

  1. Data Triangulation and Final Review:

The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.

We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.

We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.

Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Trends and growth analysis reports related to Europe Automated Compounding Systems Market